Zobrazeno 1 - 10
of 479
pro vyhledávání: '"Satoshi Saitoh"'
Autor:
Tetsuya Hosaka, Fumitaka Suzuki, Mariko Kobayashi, Shunichiro Fujiyama, Yusuke Kawamura, Hitomi Sezaki, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Satoshi Saitoh, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
Hepatology Communications, Vol 6, Iss 1, Pp 36-49 (2022)
Serum hepatitis B core‐related antigen (HBcrAg) and surface antigen (HBsAg) are surrogate markers of intrahepatic covalently closed circular DNA. The measurement range of the current HBcrAg assay is relatively narrow. Thus, we examined the potentia
Externí odkaz:
https://doaj.org/article/9bcc2e1f52af4fd2b482001f79601d36
Autor:
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Reliable noninvasive predictors of the top three causes of death [cardiovascular diseases (CVDs), malignancies, and liver-related events in patients with non-alcoholic fatty liver disease (NAFLD)] have not yet been determined. Met
Externí odkaz:
https://doaj.org/article/28b14a49534747ce92df6ef7f9fa3ab2
Autor:
Shunichiro Fujiyama, Norio Akuta, Hitomi Sezaki, Mariko Kobayashi, Yusuke Kawamura, Tetsuya Hosaka, Masahiro Kobayashi, Satoshi Saitoh, Fumitaka Suzuki, Yoshiyuki Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Hepatitis C virus is the leading cause of liver cirrhosis and hepatocellular carcinoma in Japan. We aimed to examine the long-term (> 20 years) mortality and hepatocellular carcinoma rates and associated risk factors in 1412 Japan
Externí odkaz:
https://doaj.org/article/d85836864b4448e0a5a2f94d0d19f379
Autor:
Yusuke Kawamura, Masahiro Kobayashi, Junichi Shindoh, Yuta Kobayashi, Satoshi Okubo, Licht Tominaga, Akira Kajiwara, Kayoko Kasuya, Soichi Iritani, Shunichiro Fujiyama, Tetsuya Hosaka, Satoshi Saitoh, Hitomi Sezaki, Norio Akuta, Fumitaka Suzuki, Yoshiyuki Suzuki, Kenji Ikeda, Yasuji Arase, Masaji Hashimoto, Tokuyo Kozuka, Hiromitsu Kumada
Publikováno v:
Liver Cancer, Vol 9, Iss 6, Pp 756-770 (2020)
Background: The aims of this study were to evaluate the efficacy of additional treatment, especially lenvatinib-transarterial chemoembolization (TACE) sequential therapy, for unresectable hepatocellular carcinoma (HCC). Methods: Consecutive 56 patien
Externí odkaz:
https://doaj.org/article/d67cebcee9a24e12a687c8cc4697c094
Autor:
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
Hepatology Communications, Vol 4, Iss 1, Pp 66-76 (2020)
The impact of circulating microRNA‐122 (miR‐122) on mortality in patients with histopathologically confirmed nonalcoholic fatty liver disease (NAFLD) remains unclear. We analyzed the overall survival rates in 441 Japanese patients with histopatho
Externí odkaz:
https://doaj.org/article/91103ab7d4ab4b21ba0f77a0a920990f
Autor:
Norio Akuta, Yusuke Kawamura, Yasuji Arase, Satoshi Saitoh, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Masahiro Kobayashi, Mariko Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
BMC Gastroenterology, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background The incidence of liver-related events, cardiovascular events and type 2 diabetes mellitus in patients with histopathologically confirmed NAFLD remains unclear. Methods We retrospectively investigated the incidence of liver events,
Externí odkaz:
https://doaj.org/article/b83c9fbbc3964132abd51d127188e67d
Autor:
Shunichiro Fujiyama, Satoshi Saitoh, Yusuke Kawamura, Hitomi Sezaki, Tetsuya Hosaka, Norio Akuta, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Yasuji Arase, Kenji Ikeda, Hiromitsu Kumada
Publikováno v:
BMC Gastroenterology, Vol 17, Iss 1, Pp 1-9 (2017)
Abstract Background Portal vein thrombosis (PVT) is a serious complication in liver cirrhosis with portal hypertension. We examined the treatment, recurrence and prognosis of PVT in cirrhotic patients. Methods The study subjects were all 90 cirrhotic
Externí odkaz:
https://doaj.org/article/9447bd615dd04665847849f7e51f1f71
Autor:
Tatsuya Hayashi, Satoshi Saitoh, Kei Fukuzawa, Yoshinori Tsuji, Junji Takahashi, Yusuke Kawamura, Norio Akuta, Masahiro Kobayashi, Kenji Ikeda, Takeshi Fujii, Tosiaki Miyati, Hiromitsu Kumada
Publikováno v:
Gut and Liver, Vol 11, Iss 5, Pp 674-683 (2017)
Background/AimsNoninvasive liver fibrosis evaluation was performed in patients with nonalcoholic fatty liver disease (NAFLD). We used a quantitative method based on the hepatic volume acquired from gadoxetate disodium-enhanced (Gd-EOB-DTPA-enhanced)
Externí odkaz:
https://doaj.org/article/ecac3720eb1740cd896c5c0fe3c1202d
Autor:
Koichi Hamada, Satoshi Saitoh, Noriyuki Nishino, Daizo Fukushima, Yoshinori Horikawa, Shinya Nishida, Michitaka Honda
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195173 (2018)
To evaluate the relationship between fibrosis and HCC after sustained virological response (SVR) to treatment for chronic hepatitis C (HCV).This single-center study retrospectively evaluated 196 patients who achieved SVR after HCV infection. The asso
Externí odkaz:
https://doaj.org/article/6b0f90e3feb84480b86717a77977d38a
Autor:
Akira Kajiwara, Yusuke Kawamura, Keiichi Kinowaki, Nozomu Muraishi, Soichi Iritani, Norio Akuta, Shunichiro Fujiyama, Hitomi Sezaki, Tetsuya Hosaka, Satoshi Saitoh, Masahiro Kobayashi, Yasuji Arase, Kenji Ikeda, Fumitaka Suzuki, Yoshiyuki Suzuki, Hiromitsu Kumada
Publikováno v:
Clinical Journal of Gastroenterology. 15:946-952
We report a 61-year-old man treated with betamethasone for sudden-onset deafness. Several days later, he had a temperature 38 °C. He sought care at another hospital and was admitted based on abnormal liver function tests (aspartate aminotransferase